HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
How pop health IT can aid pandemic care
Digital Checkup

How pop health IT can aid pandemic care

8:19

Enli Health Intelligence's Dr. Joseph Siemienczuk discusses the role of population health IT during COVID-19 or any pandemic.

Read More
Read Less

Digital Checkup - Similar Videos View more in Digital Checkup

7:34

Why AI is a great partner for better care delivery

According to Michael Meucci, Arcadia's president and CEO, marrying data about patients, care journeys, costs and more for AI to analyze can uncover utilization signals that providers and payers can use to enhance care delivery.

Why AI is a great partner for better care delivery
According to Michael Meucci, Arcadia's president and CEO, marrying data about patients, care journeys, costs and more for AI to analyze can uncover utilization signals that providers and payers can use to enhance care delivery.
7:34
6:04

Payer negotiation tech stacks: A primer for providers

There are challenges experienced by providers during payer negotiations, and various tech capabilities needed to build the most effective and valuable payer negotiation tech stacks. Dilpreet Sahota, founder and CEO of Trek Health, explains.

Payer negotiation tech stacks: A primer for providers
There are challenges experienced by providers during payer negotiations, and various tech capabilities needed to build the most effective and valuable payer negotiation tech stacks. Dilpreet Sahota, founder and CEO of Trek Health, explains.
6:04
7:30

PBM reform moves the system from a rebate structure to flat fees

The legislation will give greater insight into the cost of therapies, but it doesn't mean premiums or the price of drugs will go down, says Ryan Czado, chief pharmacy officer of RazorMetrics.

PBM reform moves the system from a rebate structure to flat fees
The legislation will give greater insight into the cost of therapies, but it doesn't mean premiums or the price of drugs will go down, says Ryan Czado, chief pharmacy officer of RazorMetrics.
7:30